Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 14, Issue 12

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 14, Issue 12 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 12 (2015)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

The safety of liposome bupivacaine 2 years post-launch: a look back and a look forward

Eugene R Viscusi (Professor of Anesthesiology, Director) MD

Pages: 1801-1803

Published online: 05 Oct 2015

AbstractforThe safety of liposome bupivacaine 2 years post-launch: a look back and a look forward | Full Text | References | PDF (270.4 KB)

1240 Views
2 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System

Leonor Nogueira Guerra, Maria Teresa Herdeiro, Inês Ribeiro-Vaz, Maria Inês Pinto Clérigo, Cristina Rocha, Ana Araújo, Alexandra Pêgo & Eva Rebelo Gomes

Pages: 1805-1813

Published online: 07 Nov 2015

AbstractforAdverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System | Full Text | References | PDF (355.3 KB)

271 Views
10 CrossRef citations
0Altmetric

Article

Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors

Dorota Kozielewicz, Dorota Dybowska, Kornelia Karwowska & Magdalena Wietlicka-Piszcz

Pages: 1815-1825

Published online: 29 Oct 2015

AbstractforRenal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors | Full Text | References | PDF (492 KB) | Supplemental

152 Views
2 CrossRef citations
0Altmetric

Article

Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase

Kennedy Obebi Cliff-Eribo, Imti Choonara, Alex Dodoo, Delese M Darko & Helen Sammons

Pages: 1827-1833

Published online: 05 Oct 2015

AbstractforAdverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase | Full Text | References | PDF (442.5 KB)

224 Views
5 CrossRef citations
0Altmetric

Review

Statins and their increased risk of inducing diabetes

Aris P Agouridis, Michael S Kostapanos & Moses S Elisaf MD, FRSPH, FASA

Pages: 1835-1844

Published online: 05 Oct 2015

AbstractforStatins and their increased risk of inducing diabetes | Full Text | References | PDF (506.2 KB)

687 Views
24 CrossRef citations
0Altmetric

Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media

Rajesh Ghosh & David Lewis

Pages: 1845-1853

Published online: 05 Oct 2015

AbstractforAims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media | Full Text | References | PDF (1.4 MB)

726 Views
41 CrossRef citations
0Altmetric

The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?

Richard. G Kiel & Prakash Deedwania

Pages: 1855-1863

Published online: 21 Oct 2015

AbstractforThe safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified? | Full Text | References | PDF (331.3 KB)

577 Views
10 CrossRef citations
0Altmetric

Risks associated with drug treatments for kidney stones

Nadya E. York, Michael S. Borofsky & James E. Lingeman

Pages: 1865-1877

Published online: 24 Nov 2015

AbstractforRisks associated with drug treatments for kidney stones | Full Text | References | PDF (273.3 KB)

511 Views
10 CrossRef citations
0Altmetric

SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment

André J. Scheen

Pages: 1879-1904

Published online: 29 Oct 2015

AbstractforSGLT2 inhibition: efficacy and safety in type 2 diabetes treatment | Full Text | References | PDF (356.6 KB)

2419 Views
46 CrossRef citations
0Altmetric

Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database

Matteo Nicola Dario Di Minno, Salvatore Iervolino, Carmela Zincarelli, Roberta Lupoli, Pasquale Ambrosino, Paolo Pizzicato, Alessandro Di Minno, Nicola Pappone & Rosario Peluso

Pages: 1905-1913

Published online: 30 Nov 2015

AbstractforCardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database | Full Text | References | PDF (359 KB)

389 Views
10 CrossRef citations
0Altmetric

Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases

Itishree Trivedi & Stephen B Hanauer

Pages: 1915-1934

Published online: 11 Nov 2015

AbstractforBalancing the risks and benefits of biologic therapy in inflammatory bowel diseases | Full Text | References | PDF (424.5 KB)

546 Views
3 CrossRef citations
0Altmetric

Drug Safety Evaluation

Article

Drug safety evaluation of lenvatinib for thyroid cancer

Jolanta Krajewska, Aleksandra Kukulska & Barbara Jarzab

Pages: 1935-1943

Published online: 20 Oct 2015

AbstractforDrug safety evaluation of lenvatinib for thyroid cancer | Full Text | References | PDF (239.2 KB)

554 Views
12 CrossRef citations
0Altmetric

Article

Ofatumumab for treating chronic lymphocytic leukemia: a safety profile

Anna Korycka-Wołowiec, Dariusz Wołowiec & Tadeusz Robak

Pages: 1945-1959

Published online: 13 Nov 2015

AbstractforOfatumumab for treating chronic lymphocytic leukemia: a safety profile | Full Text | References | PDF (444.1 KB)

301 Views
12 CrossRef citations
0Altmetric

Article

A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis

Nico M Wulffraat

Pages: 1961-1967

Published online: 14 Nov 2015

AbstractforA safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis | Full Text | References | PDF (217.8 KB)

416 Views
13 CrossRef citations
0Altmetric

Article

Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis

Brian Berman MD PhD

Pages: 1969-1978

Published online: 02 Nov 2015

AbstractforSafety and tolerability of ingenol mebutate in the treatment of actinic keratosis | Full Text | References | PDF (348.6 KB)

430 Views
12 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

An update on the safety of lanreotide autogel for the treatment of patients with neuroendocrine tumors

Aayushi Sood et al.

Review Article | Published online: 10 Jun 2024

Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS)

Roger S. McIntyre et al.

Article | Published online: 3 Jun 2024

Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach

Desirèe Speranza et al.

Review Article | Published online: 3 Jun 2024

An overview of the efficacy and safety of β₂-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease

Maria Gabriella Matera et al.

Review Article | Published online: 2 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.14, Iss.12, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?